By disrupting toxic Aβ interactions, reducing excitotoxicity, and alleviating neuroinflammation, mGluR5 inhibition may confer neuroprotection and potentially slow the progression of AD [84]. The gene discussed is GRM5; the disease is Alzheimer disease.